Application Sponsors
ANDA 214277 | NOVITIUM PHARMA | |
Marketing Status
Application Products
001 | SUSPENSION;ORAL | 100MG/5ML | 0 | CARBAMAZEPINE | CARBAMAZEPINE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2022-10-06 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
NOVITIUM PHARMA
cder:Array
(
[0] => Array
(
[ApplNo] => 214277
[companyName] => NOVITIUM PHARMA
[docInserts] => ["",""]
[products] => [{"drugName":"CARBAMAZEPINE","activeIngredients":"CARBAMAZEPINE","strength":"100MG\/5ML","dosageForm":"SUSPENSION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"10\/06\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2022-10-06
)
)